Loading...
•
Mar 31, 2020
Orthofix Q1 2020 Earnings Report
Orthofix reported a decrease in net sales but an increase in net income and EPS compared to the prior year period.
Key Takeaways
Orthofix Medical Inc. reported a decrease in net sales by 3.9% to $104.8 million for the first quarter ended March 31, 2020. However, the company's diluted earnings per share (EPS) was $1.32, and adjusted EPS was $0.09. The company proactively responded to COVID-19 challenges to ensure balance sheet and capital liquidity.
Net sales decreased by 3.9% compared to the prior year, reaching $104.8 million.
Diluted earnings per share (EPS) was $1.32, while adjusted EPS was $0.09.
Gross profit decreased to $81.4 million, with a gross margin of 77.7%.
The company borrowed $100.0 million against its secured revolving credit facility to navigate the uncertain macro-environment.
Revenue by Segment
Forward Guidance
Due to the uncertainty related to the COVID-19 pandemic, Orthofix is not providing quantitative guidance for the second quarter of 2020 or for the full year at this time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...